Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital, Milan, Italy.
Vita-Salute San Raffaele University and Division of Transplantation, Immunology and Transplantation Diseases, San Raffaele Scientific Institute, Milan, Italy.
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e602-e614. doi: 10.1210/clinem/dgaa738.
COVID-19 has become the most relevant medical issue globally. Despite several studies that have investigated clinical characteristics of COVID-19 patients, no data have been reported on the prevalence of vertebral fractures (VFs). Since VFs may influence cardiorespiratory function and disease outcomes, the aim of this study was to assess VFs prevalence and clinical impact in COVID-19.
This was a retrospective cohort study performed at San Raffaele Hospital, a tertiary health care hospital in Italy. We included COVID-19 patients for whom lateral chest x-rays at emergency department were available. VFs were detected using a semiquantitative evaluation of vertebral shape on chest x-rays.
A total of 114 patients were included in this study and thoracic VFs were detected in 41 patients (36%). Patients with VFs were older and more frequently affected by hypertension and coronary artery disease (P < 0.001, P = 0.007, P = 0.034; respectively). Thirty-six (88%) patients in VFs+ group compared to 54 (74%) in VFs- group were hospitalized (P = 0.08). Patients with VFs more frequently required noninvasive mechanical ventilation compared with those without VFs (P = 0.02). Mortality was 22% in VFs+ group and 10% in VFs- group (P = 0.07). In particular, mortality was higher in patients with severe VFs compared with those with moderate and mild VFs (P = 0.04).
VFs may integrate the cardiorespiratory risk of COVID-19 patients, being a useful and easy to measure clinical marker of fragility and poor prognosis. We suggest that morphometric thoracic vertebral evaluation should be performed in all suspected COVID-19 patients undergoing chest x-rays.
COVID-19 已成为全球最重要的医学问题。尽管已有多项研究调查了 COVID-19 患者的临床特征,但尚未有研究报告椎体骨折(VF)的患病率。由于 VF 可能影响心肺功能和疾病结局,因此本研究旨在评估 COVID-19 患者 VF 的患病率及其临床影响。
这是一项在意大利一家三级保健医院 San Raffaele 医院进行的回顾性队列研究。我们纳入了急诊科有侧位胸部 X 线片的 COVID-19 患者。通过胸部 X 线片上的半定量评估椎骨形状来检测 VF。
本研究共纳入 114 例患者,其中 41 例(36%)患者存在胸段 VF。VF 患者年龄较大,且更常患有高血压和冠心病(P<0.001、P=0.007、P=0.034;分别)。VF+组中 36 例(88%)患者与 VF-组中 54 例(74%)患者住院治疗(P=0.08)。与无 VF 患者相比,VF 患者更常需要无创机械通气(P=0.02)。VF+组的死亡率为 22%,VF-组为 10%(P=0.07)。特别是,严重 VF 患者的死亡率高于中度和轻度 VF 患者(P=0.04)。
VF 可能是 COVID-19 患者心肺风险的一个组成部分,是一种有用且易于测量的脆性和不良预后的临床标志物。我们建议对所有疑似 COVID-19 患者进行胸部 X 线检查时,应进行形态计量学胸椎评估。